Cancer Detection and Diagnosis Research in Michigan
Cancer Detection and Diagnosis Research (93.394) awarded $75.3 million to recipients in Michigan in 54 grants from fiscal 2021 to 2025, 2.8% of the program's national total. Regents of the University of Michigan received the most, $57.5 million.
- Awarded in Michigan$75.3 million
- Awards54
- Share of the program2.8%
- Rank among states12th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 36 | $18.3 million |
| FY 2022 | 32 | $17.6 million |
| FY 2023 | 26 | $13.8 million |
| FY 2024 | 27 | $13.4 million |
| FY 2025 | 22 | $12.1 million |
Recipients in Michigan
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Regents of the University of Michigan | Colleges and universities | 39 | $57.5 million |
| Van Andel Research Institute | Nonprofits | 3 | $4.5 million |
| Wayne State University | Colleges and universities | 3 | $3.7 million |
| Henry Ford Health System | Nonprofits | 2 | $2.7 million |
| Michigan State University | Colleges and universities | 2 | $2.5 million |
| William Beaumont Hospital | Nonprofits | 1 | $2.3 million |
| Lynx DX Inc | Small businesses | 1 | $995,327 |
| Michigan Technological University | Colleges and universities | 1 | $455,433 |
| Alelopharma Inc. | Small businesses | 1 | $399,153 |
| Northern Michigan University | Colleges and universities | 1 | $194,787 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 50 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Michigan?
$75.3 million from fiscal 2021 to 2025, across 54 awards. Michigan ranks 12th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Michigan?
The largest recipient is Regents of the University of Michigan, with $57.5 million in 39 awards. Next are Van Andel Research Institute and Wayne State University.
Can organizations in Michigan apply now?
Yes, 50 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Michigan
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Temporary Assistance for Needy Families
- National School Lunch Program
- Commercial Technologies for Maintenance Activities Program
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Child Care and Development Block Grant
- Head Start